Ann Marie Navar, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111
In Their Words

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005

Publications

Hess, Paul, Kevin Kennedy, Michael Cowherd, Salim Virani, Frederick Masoudi, Ann Marie Navar, Robert Yeh, and Thomas Maddox. “IMPLICATIONS OF THE FDA APPROVAL OF PCSK9 INHIBITORS FOR CONTEMPORARY CARDIOVASCULAR PRACTICE: FINDINGS FROM THE NCDR (R) RESEARCH TO PRACTICE (R2P) PROJECT.” In Journal of the American College of Cardiology, 69:1661–1661. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Navar, Ann Marie, Dylan Steen, Daniel Wojdyla, Robert Sanchez, Irfan Khan, Eric Peterson, and Michael Pencina. “RECURRENT CARDIOVASCULAR EVENT RATES IN A CONTEMPORARY COHORT OF 829,498 ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.” In Journal of the American College of Cardiology, 69:59–59. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Goldstein, Benjamin A., Ann Marie Navar, Michael J. Pencina, and John P. A. Ioannidis. “Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review..” J Am Med Inform Assoc 24, no. 1 (January 2017): 198–208. https://doi.org/10.1093/jamia/ocw042.

PMID
27189013
Full Text

Navar, A. M., E. D. Peterson, and D. Wojdyla. “Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence (vol 316, pg 2041, 2016).” Jama Journal of the American Medical Association 316, no. 22 (December 13, 2016): 2433–2433.

Scholars@Duke

Goldstein, Benjamin A., Ann Marie Navar, and Michael J. Pencina. “Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context..” Jama Cardiol 1, no. 9 (December 1, 2016): 976–77. https://doi.org/10.1001/jamacardio.2016.3826.

PMID
27732706
Full Text

Navar, Ann Marie, Eric D. Peterson, Daniel Wojdyla, Robert J. Sanchez, Allan D. Sniderman, Ralph B. D’Agostino, and Michael J. Pencina. “Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence..” Jama 316, no. 19 (November 15, 2016): 2041–43. https://doi.org/10.1001/jama.2016.13614.

PMID
27838711
Full Text

Navar, Ann Marie, and Eric D. Peterson. “Evolving Approaches for Statins in Primary Prevention: Progress, but Questions Remain..” Jama 316, no. 19 (November 15, 2016): 1981–83. https://doi.org/10.1001/jama.2016.15094.

PMID
27838704
Full Text

Fanaroff, Alexander C., Ann Marie Navar, Robert Clare, Yuliya Lokhnygina, Matthew Roe, Robert Giugliano, Andrew Tershakovec, and Michael Blazing. “Association of Type of Presentation, STEMI vs NSTEMI/UA, With the Relative Long-Term Incidence of Cardiovascular and Non-Cardiovascular Mortality.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.

Scholars@Duke

Whelton, Paul K., Paula T. Einhorn, Paul Muntner, Lawrence J. Appel, William C. Cushman, Ana V. Diez Roux, Keith C. Ferdinand, et al. “Research Needs to Improve Hypertension Treatment and Control in African Americans..” Hypertension 68, no. 5 (November 2016): 1066–72. https://doi.org/10.1161/HYPERTENSIONAHA.116.07905.

PMID
27620388
Full Text

Navar, Ann Marie, Michael J. Pencina, and Eric D. Peterson. “Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment..” Jama Cardiol 1, no. 8 (November 1, 2016): 864–71. https://doi.org/10.1001/jamacardio.2016.2861.

PMID
27604060
Full Text

Pages